Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10 ng/ml at Initial Biopsy

Publication date: Available online 22 March 2019Source: European UrologyAuthor(s): Fumihiko Urabe, Takahiro Ochiya, Shin Egawa

Source: European Urology - March 22, 2019 Category: Urology & Nephrology Source Type: research

More News: Cancer | Cancer & Oncology | Genetics | Prostate Cancer | Urology & Nephrology

Re: A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2–10&nbsp;ng/ml at Initial Biopsy